Embodiments of the invention relate generally to a medical connector for the removal of fluids from a patient and administration of medicaments to a patient. More specifically, embodiments of the invention are directed to a T-site connector to allow medical staff to efficiently access a patient's blood vessel.
The insertion of peripheral intravenous catheters and peripheral blood collection needles are clinical practices commonly performed by clinicians and phlebotomists. When patients have small, damaged, collapsed veins or other symptoms and conditions such as dehydration and low blood pressure, this can further complicate the insertion of these devices into the patient's blood vessels.
The average hospitalized patient will encounter a stainless-steel needle placement or insertion (“stick”) every time a physician orders a blood test. This can occur as frequently as once an hour for arterial blood gas samples or more routinely twice a day. The standard procedure for blood sampling involves using a stainless-steel needle to enter or stick a selected vein in the patient's hand, forearm, or antecubital fossa.
Blood sampling is labor intensive and time consuming for clinician and phlebotomist. A single needle stick blood sampling procedure can take between 3 to 20 minutes for each blood sample. Blood collection is also painful and a major source of patient anxiety and discomfort. The patient's pain, discomfort and anxiety are further elevated when difficulty in finding a proper vein for blood sampling results in multiple needle sticks. Furthermore, multiple sticks also involve additional material expense as well as additional clinician and phlebotomist time.
A particular group of patients may additionally be defined to have Difficult Intravenous Access (DIVA), which is very few or no superficial vein access. In some cases, ultrasound may be used to assess the patient's vein in order to find a deeper more viable source for blood collection.
In most hospitalized patients (>90%), peripheral IV catheters are commonly used for the infusion of IV fluids, medications, drugs, and blood. Peripheral IV catheters, when placed into a larger vein in the forearm, may have a faster and higher volumetric blood flow than the peripheral IV catheter placed in the hand or wrist. When hospitalized, patients may use an anti-reflux needleless connector to protect the catheter lumen from unintentional blood aspiration, which can also lead to blood clots.
Due to the pain, trauma, anxiety and discomfort for the patient and the time-consuming nature of finding a proper functioning vein for an efficient blood draw, there is a need for a well-placed peripheral IV catheter that can be used successfully for blood collection.
Embodiments of the invention solve the above-mentioned problems by providing a single intravenous T-site connector, system, method of administration, blood sampling, and collection. The single intravenous T-site connector is configured to be used with a standard peripheral IV catheter that is inserted into the patient's forearm. The T-site connector is secured to the catheter to allow for at least one needleless connector to be secured to the primary access port for the injection and infusion of medicaments and the withdrawal of blood via the T-Site connector while connected to the patient's Peripheral IV catheter, which is inserted in the patient's forearm or other viable vein. This allows the catheter to be used for multiple purposes.
In some aspects, the techniques described herein relate to a T-site connector configured to fluidly attach a syringe with a blood vessel of a patient, the T-site connector including: a T-site body including: a septum housing at a proximal end having a primary luer body extending distally therefrom and defining a primary fluid passageway; and a tube bond stem extending axially from the primary luer body and defining a secondary fluid passageway therein, the primary fluid passageway and the secondary fluid passageway being fluidly coupled at a central fluid chamber; an externally threaded cap including: a proximal face disposed at a proximal end of the externally threaded cap, the proximal face including a bore therethrough, the bore defining a first diameter; an external wall extending distally from the proximal face and having one or more external threads disposed circumferentially therearound; and an inner flange extending distally from the proximal face and within the external wall, the inner flange defining a second diameter being larger than the first diameter; and a septum housed within the inner flange and the septum housing, the septum including a slit therethrough, the slit being accessible through the bore.
In some aspects, the techniques described herein relate to an injection apparatus, including: a T-site connector and a locking cannula, the T-site connector including: a T-site body, a septum, and an externally threaded cap, the T-site body including a septum housing fluidly coupled to a primary luer body and a tube bond stem; the septum including a swabbable face having a slit therethrough and extending to a distal wall, the septum having a pre-use position and an in-use position; the externally threaded cap secured to the septum housing of the T-site body and including a proximal face and an external wall extending distally therefrom, the external wall including one or more external threads disposed thereon, wherein the septum is retained between portions of the externally threaded cap and the septum housing; the locking cannula including: a cannula having a proximal annular base connected to a cannula tip and defining a cannula fluid path therein; and an internally threaded collar segment receiving the cannula tip therein and being rotatable therearound, wherein the internally threaded collar segment includes one or more internal threads configured to rotatably attach to the one or more external threads of the externally threaded cap.
In some aspects, the techniques described herein relate to a system for controlling flow of liquids to and from a patient, including: a T-site connector including: a T-site body extending longitudinally between a proximal end and a distal end, wherein the proximal end includes a septum housing and the distal end includes a primary luer body having a tube bond stem disposed therebetween and extending axially in relation to the longitudinal direction; a septum disposed within the septum housing, the septum including a slit therethrough; an externally threaded cap disposed at the proximal end, the externally threaded cap including: a proximal face having a bore therethrough; an external wall extending distally from the proximal face and having one or more external threads disposed therearound, wherein the externally threaded cap is secured to the septum housing, thereby retaining the septum within the septum housing; and a first internally threaded collar disposed at the primary luer body and being rotatable therearound; a locking cannula including: a cannula; and a second internally threaded collar receiving a portion of the cannula therethrough, the second internally threaded collar including one or more internal threads configured to receive the one or more external threads of the externally threaded cap.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. Other aspects and advantages of the present invention will be apparent from the following detailed description of the embodiments and the accompanying drawing figures.
Embodiments of the present invention are described in detail below with reference to the attached drawing figures, wherein:
The drawing figures do not limit the invention to the specific embodiments disclosed and described herein. The drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the invention.
The subject matter of the invention is described in detail below to meet statutory requirements; however, the description itself is not intended to limit the scope of claims. Rather, the claimed subject matter might be embodied in other ways to include different steps or combinations of steps similar to the ones described in this document, in conjunction with other present or future technologies. Minor variations from the description below will be understood by one skilled in the art and are intended to be captured within the scope of the claimed invention. Terms should not be interpreted as implying any particular ordering of various steps described unless the order of individual steps is explicitly described.
The following detailed description of embodiments of the invention references the accompanying drawings that illustrate specific embodiments in which the invention can be practiced. The embodiments are intended to describe aspects of the invention in sufficient detail to enable those skilled in the art to practice the invention. Other embodiments can be utilized and changes can be made without departing from the scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense. The scope of the invention is defined only by the appended claims, along with the full scope of equivalents to which such claims are entitled.
In this description, references to “one embodiment,” “an embodiment,” or “embodiments” mean that the feature or features being referred to are included in at least one embodiment of the technology. Separate references to “one embodiment,” “an embodiment,” or “embodiments” in this description do not necessarily refer to the same embodiment and are also not mutually exclusive unless so stated and/or except as will be readily apparent to those skilled in the art from the description. For example, a feature, structure, act, etc. described in one embodiment may also be included in other embodiments but is not necessarily included. Thus, the present technology can include a variety of combinations and/or integrations of the embodiments described herein.
Turning to
Reference will be made herein to various orientations and dimensions of the T-site connector 10 and its components. As used herein, the T-site connector 10 and its components have longitudinal lengths that extend in a direction of a primary fluid passageway 46 (see
The various components of T-site connector 10 will now be discussed in more detail. It should be appreciated that T-site connectors of various embodiments may include any or all of the below-discussed components and may include additional components or the equivalents thereof. T-site connector 10 may also be used in connection with one of more of the below-discussed methods.
With respect to
In some embodiments, T-site body 26 comprises a molded rigid thermoplastic resin (such as MAKROLON® by BAYER®). In some embodiments, primary luer body 28 and tube bond stem 30 of T-site body 26 may be integrally formed to present a unitary, monolithic structure.
Tube bond stem 30 extends generally perpendicularly from primary luer body 28 and presents a secondary fluid passageway 48 (see
As shown in
Primary fluid passageway 46 extends the longitudinal length, or almost the entire longitudinal length, of primary luer body 28, as best illustrated in
In some embodiments and as illustrated in
In embodiments, recess 58 provides access to central fluid chamber 50, as illustrated in
Returning now to
As noted above, internally threaded collar 32 is removably coupled to catheter 12. As shown in
Before discussing slit septum 34 in detail, cannula 24 will be briefly described, as is illustrated in
In some embodiments, slit septum 34 is formed of a synthetic isoprene with silica filler that may be free of natural rubber, latex, or mercaptobenzimidazol and has a hardness of between about 36 Shore A to about 41 Shore A. In some embodiments, the slit septum 34 is resilient and compressible. For example, in some embodiments slit septum 34 is compressible along both a longitudinal length and a transverse width. Slit septum 34 may be hermetically sealed within T-site connector 10 to significantly minimize or completely prevent the expulsion of fluids out of slit 44 in slit septum 34, that may otherwise occur upon removal of cannula 24 from slit 44.
In some embodiments, slit septum 34 is formed as a single, monolithic unit. The “pre-use position,” as referenced herein, is the position of slit septum 34 located within externally threaded cap 36 and septum housing 42 while externally threaded cap 36 is secured to annular protrusion 54 of septum housing 42, as illustrated in
Slit 44 is formed in slit septum 34 and extends along the entire longitudinal length of slit septum 34. In some embodiments, slit 44 comprises a single slit through slit septum 34. In other embodiments, slit 44 comprises a plurality of slits (not illustrated) formed in slit septum 34. For example, two slits may be formed in slit septum 34. In yet further embodiments, three or more slits may be formed in slit septum 34, such as tri-slit formed in a Y-shape. When slit septum 34 is in the pre-use or rest positions, slit 44 and slit septum 34 are in a closed position, i.e., fluid does not flow through slit 44. Upon insertion of cannula 24, or a needle or other medical device, into slit 44, slit septum 34 transitions to the “in use” position, thereby fluidly coupling cannula 24 and/or associated medical devices with T-site connector 10.
Slit septum 34 is secured to primary luer body 28 via externally threaded cap 36, as best illustrated in
In one example, the proximal connection device may be an antiseptic cap (such as an alcohol cap, not illustrated) configured to prevent or reduce infection by the transfer of cannula 24 into and out of slit septum 34. In another example, the proximal connection device may be a lever-locking cannula 16 (illustrated in
Externally threaded cap 36 presents a generally open-ended cylinder shape, as best illustrated in
In some embodiments, externally threaded cap 36 comprises a cap segment 98 and external-threaded segment 94, as best illustrated in
The external-threaded segment 94 presents an outer wall 102 and a one or more external threads 104, such as a helical ridge, protruding or otherwise extending radially therefrom. In some embodiments, and as discussed below with respect to one or more external threads 234, one or more external threads 104 comprise two, three, four, or more threads. In some embodiments, one or more external threads 104 comprise three threads. The one or more external threads 104 allow for a medical device (e.g., threaded-locking cannula 18) to be secured thereto, through rotation of internally threaded collar 32, primary luer body 28, or both (as illustrated in
In some embodiments, externally threaded cap 36 presents an inner proximal taper shape (which may be within cap segment 98 and/or external-threaded segment 94), as best illustrated in
The taper shape of the tapered annular void 112 will now be discussed in more detail. As illustrated in
As mentioned above, tapered annular void 112 is configured to receive portions of slit septum 34 upon insertion of cannula 24 into slit 44, due to the elastomeric expansion of slit septum 34. Because of the respective axial widths, elastomeric expansion takes place with the motion of the cannula 24 being inserted into the slit septum 34. As such, the tapered annular void 112 is filled in a proximal to distal direction as the cannula 24 is inserted.
In some embodiments in which cannula 24 is twisted during attachment, the screwing motion of inserting the cannula 24, when compared to traditional methods of straight insertion, allows for additional torque to be applied. The additional torque may overcome additional pressure placed on slit septum 34 due to the bounds of septum housing 42. The screwing action may also straighten cannula 24 and prevent piercing the walls of slit septum 34.
Various exemplary proximal connection devices will now be discussed. The discussed proximal connection devices may be connected to primary luer body 28 and/or tube bond stem 30. It should be appreciated that any of numerous types of medical devices may be secured to primary luer body 28 via slit septum 34 and/or tube bond stem 30. Four exemplary structures are depicted in
An example of the lever-locking cannula 16 is illustrated in
The lever-locking cannula 16, as illustrated in
Some embodiments of the threaded-locking cannula 18 are illustrated in
Some embodiments of tube set 20 are illustrated in
As in the example shown in
Each access port 22 and/or flow lock 134 may be of a certain color or have some other distinguishing mark or characteristic. This is because each access port 22 may be used for a single purpose (as discussed below with respect to
In some embodiments, cannula 24 presents a length configured to terminate at the central fluid chamber 50. This reduces the blood and other fluids that come in contact with cannula 24. As cannula 24 is removed from slit septum 34, the blood or other fluids may be deposited along slit septum 34 or in other proximate locations, which can lead to blood stream infections and other complications. In some embodiments, cannula 24 presents a length that is slightly less than a length of slit septum 34 such that cannula 24 will terminate while still slightly within slit septum 34 to further reduce the contact between blood and other fluids with cannula 24. It should be appreciated that while
As depicted, T-site connector 200 may have some similar components, connectivity, and structure as portions of T-site connector 10. As will be appreciated and described below, in some embodiments, T-site connector 200 and T-site connector 10 have exchangeable portions. For example, internally threaded collar 32, which may be secured to primary luer body 28, as described above, may similarly be secured to primary luer body 204 (not shown). Similarly, in some embodiments T-site connector 10 and T-site connector 200 may share similar structural features. For example, similar to the one or more inner gripping protrusions disposed on primary luer body 28 of T-site connector 10, T-site connector 200 may include one or more gripping protrusions 212 disposed on primary luer body 204 so as to capture internally threaded collar 32. In some embodiments, T-site connector 10 and T-site connector 200 may include differing components or structures. For example, externally threaded cap 36 of T-site connector 10 may comprise a different outer diameter than externally threaded cap 230 of T-site connector 200. These examples should not be construed as limiting the similarities or differences between T-site connector 10 and T-site connector 200. As mentioned previously, any number of combinations of parts may or may not be shared between T-site connector 10 and T-site connector 200.
T-site connector 200 includes a proximal end 200a and a distal end 200ib. In some embodiments, T-site connector 200 includes a T-site body 202 extending from the proximal end 200a to the distal end 200b. As shown in
As briefly mentioned above, in some embodiments primary luer body 204 may include one or more gripping protrusions 212 extending radially outward therefrom. In some embodiments, primary luer body 204 may include capturing portion 214 located proximally to one or more gripping protrusions 212. Capturing portion 214 may comprise a smaller radius than one or more gripping protrusions 212. Similar to the description above, one or more gripping protrusions 212 and capturing portion 214 may retain and/or secure an internally threaded collar (e.g., internally threaded collar 32) thereto. Also similar to the above description, one or more gripping protrusions 212 may prevent distal movement of the internally threaded collar (e.g., internally threaded collar 32) past a certain point. However, the internally threaded collar (e.g., internally threaded collar 32) may not be attached or adhered to primary luer body 204 such that the internally threaded collar may freely rotate around primary luer body 204 allowing primary luer body 204 to securely attach to a VAD (e.g., catheter 12) by way of the internally threaded collar.
In some embodiments, T-site connector 200 includes tube bond stem 208 defining a secondary fluid passageway 210 therethrough. Similar to descriptions above, secondary fluid passageway 210 intersects primary fluid passageway 206 at a central fluid chamber 222, such that fluids administered via tube bond stem 208 pass through secondary fluid passageway 210 and to primary fluid passageway 206. Accordingly, medicaments may be administered via tube bond stem 208.
In some embodiments, T-site body 202 includes septum housing 216 extending longitudinally towards proximal end 200a. In some embodiments, septum housing 216 may be configured to house a portion, or all of septum 260. Furthermore, septum housing 216 may engage a portion of septum 260 so as to prevent or preclude distal movement of septum 260 when attaching T-site connector 200 to a cannula (e.g., cannula 290 depicted in
As depicted in
In some embodiments, portions of septum 260 are accessible while septum 260 is secured within septum housing 216 via externally threaded cap 230. For example, as depicted in
Similar to T-site connector 10, various proximal medical devices 128 may be connected to T-site connector 200 at proximal end 200a and/or tube bond stem 208. Three exemplary structures are shown in
Externally threaded cap 230 will now be discussed in greater detail.
In some embodiments externally threaded cap 230 includes external wall 232 extending distally from proximal face 236. External wall 232 includes one or more external threads 234 projecting radially outwardly therefrom and configured to fasten to an internally threaded collar (e.g., internally threaded collar segment 282 depicted in
In some embodiments, the number and structure of external threads 234 may be adjusted such that different degrees of rotation of internally threaded collar segment 282 may be required to fully fasten internally threaded collar segment 282 to externally threaded cap 230. For example, in some embodiments one or more external threads 234 may comprise two threads. In these embodiments, rotation of internally threaded collar segment 282 between about 330 degrees to about 370 degrees may fully fasten internally threaded collar segment 282 to externally threaded cap 230 (e.g., upon full reception of externally threaded cap 230 within internally threaded collar segment 282, such as depicted in
Further, as depicted in
As is apparent from the above description, an increase in the number of one or more external threads 234 and internal threads 288 leads to a decrease in the degrees of rotation necessary to secure internally threaded collar segment 282 to externally threaded cap 230. Similarly, an increase in angle α and/or a decrease in angle β leads to a decrease in the degrees of rotation necessary to secure internally threaded collar segment 282 to externally threaded cap 230. However, there may be limitations to the number of one or more external threads 234 and internal threads 288 that will still allow for rotational connection of internally threaded collar segment 282 to externally threaded cap 230. For example, increasing the number of one or more external threads 234 and internal threads 288 may decrease the likelihood of internal threads 288 receiving one or more external threads 234 therein upon rotation. Accordingly, a certain number of threads and angle of angle α and angle β may be used to optimize the operator's fastening of externally threaded cap 230 to internally threaded collar segment 282. In exemplary embodiments, one or more external threads 234 may comprise three threads, angle α may be about 110 degrees, and angle β may be about 120 degrees. It should be understood that the above is merely illustrative, and any number of one or more external threads 234, and degree of angle α and angle β may be chosen to optimize the ability of an operator to rotationally secure internally threaded collar segment 282 to externally threaded cap 230. It is to be further understood that any number of threaded portions on T-site connector 10 or T-site connector 200 may similarly be configured to enhance the capability of a user to secure components to T-site connector 10 or T-site connector 200. For example, in some embodiments externally threaded cap 36 may comprise three threads 104. In another example, internally threaded collar 32 may comprise internal threads 70 configured to receive and secure to a device having three external threads. In another example, internally threaded collar segment 126 may comprise internal threads configured to receive and secure to a device having three external threads.
As briefly described above and depicted in
In some embodiments, inner flange 238 terminates distally at axial wall 242. As will be discussed in greater detail below, axial wall 242 may be configured to abut septum flange 268 when T-site connector 200 is assembled, thereby helping to maintain positioning of septum 260 within T-site connector 200.
As described above, inner flange 238 may further include an outer wall 254. In some embodiments, outer wall 254 connects to septum barrier wall 246 via axial wall 242. Further, as illustrated in
As briefly described above, outer flange 252 may define septum housing reception wall 250 located internally. In embodiments, septum housing reception wall 250 defines a greater diameter than outer wall 254. As such, outer wall 254 and septum housing reception wall 250 define pocket 248 therebetween, whereby pocket 248 is configured to receive some or all of septum housing 216 therein (e.g., see
As briefly mentioned above, septum 260 includes swabbable face 262 containing slit 264 therethrough. In embodiments, slit 264 extends longitudinally through the entirety of septum 260. Similar to slit 44, slit 264 is configured to receive a cannula therethrough. Septum 260 also includes septum wall 266 extending distally from swabbable face 262. When T-site connector 200 is assembled, some of all of septum wall 266 may abut septum barrier wall 246 of externally threaded cap 230. Such abutment of septum wall 266 against septum barrier wall 246 may aid in maintaining septum 260 in a closed, or pre-use position. Further, abutment of septum wall 266 against septum barrier wall 246 may aid in maintaining a seal of slit 264 against a cannula tip (e.g., cannula tip 298 of cannula 290) when extending therethrough (i.e., when septum 260 is in the “in use” position).
In some embodiments, septum 260 includes a septum flange 268 extending radially outward from septum wall 266 at the distal end of septum 260. As illustrated in
In some embodiments, septum flange 268 includes housing protrusion 270 extending distally therefrom. As illustrated in
Septum 260 includes a distal wall 272. When T-site connector 200 is assembled, distal wall 272 leads to central fluid chamber 222. Distal wall 272 may comprise a concave (e.g., as illustrated in
Similar to threaded-locking cannula 18 described above, locking cannula 280 may attach to T-site connector 200 at proximal end 200a, thereby allowing connection of syringe 19 or other proximal medical device 128 to T-site connector 200. Locking cannula 280 includes an internally threaded collar segment 282 and a cannula 290. Internally threaded collar segment 282 includes a proximal wall 284 having a hole 284a that receives a portion of cannula 290 therethrough. Internally threaded collar segment 282 may include a retention feature to maintain attachment of internally threaded collar segment 282 to cannula 290 when received therein. For example, in some embodiments internally threaded collar segment 282 may include an inner ridge 286 disposed within hole 284a and configured to engage a portion of cannula 290 (e.g., protruding ridge 296) when cannula 290 is received therein.
Internally threaded collar segment 282 includes one or more internal threads 288 configured to receive one or more external threads 234 of externally threaded cap 230 therein. Similar to embodiments described above in relation to one or more external threads 234, one or more internal threads 288 may comprise one, two, three, four, or more internal threads. In embodiments, the number of external threads 234 and internal threads 288 is the same. In some embodiments, one or more external threads 234 comprises three threads and one or more internal threads 288 comprises three threads.
Cannula 290 includes a proximal annular base 292 similar to proximal annular base 84. In embodiments, proximal annular base 292 allows for secure attachment of cannula 290 to a syringe (e.g., syringe 19) or other proximal medical device 128. Further, cannula 290 includes cannula fluid path 294 therethrough, extending from proximal annular base 292 to cannula tip 298. As will be discussed below, cannula fluid path 294 allows for fluid flow between syringe 19 or other proximal medical device 128 and T-site connector 200 when locking cannula 280 is attached to T-site connector 200.
Referring now to
In some embodiments, septum 260 is formed of a synthetic isoprene with silica filler that may be free of natural rubber, latex, or mercaptobenzimidazol and has a hardness of between about 36 Shore A to about 41 Shore A. In some embodiments, the septum 260 is resilient and compressible. Septum 260 may be compressible along both the longitudinal length and a transverse width. Septum 260 may be hermetically sealed within the T-site connector 200 to significantly minimize or completely prevent the expulsion of fluids out of slit 264 in septum 260, that may otherwise occur upon removal of cannula tip 298 from slit 264.
The length of cannula tip 298 may be such that once internally threaded collar segment 282 is fully rotated and secured onto externally threaded cap 230, cannula tip 298 may extend distally through slit 264 and past distal wall 272, placing septum 260 in the “in use” position. Furthermore, the configuration and sizing of slit 264, septum 260, and cannula tip 298 is such that a friction fit forms between cannula tip 298 and septum 260, thereby preventing fluid movement therebetween. Thus, once locking cannula 280 is fully attached to externally threaded cap 230, a complete fluid path is formed from cannula fluid path 294 to central fluid chamber 222 and primary fluid passageway 206. Such a configuration allows for the exchange of fluids and/or medicaments between syringe 19, or other proximal medical device 128, and the patient.
In some embodiments, such as is depicted in
As discussed above, additional proximal connection devices may be connected to T-site connector 10 and/or T-site connector 200. Some embodiments of a proximal connection device, collar-locking cannula 300, are depicted in
In some embodiments, collar 304 includes retaining wall 306 having collar extension 308 extending therefrom and defining retention aperture 310. In some embodiments, collar 304 includes guiding wall 312 configured to guide tube bond stem 30 as tube bond stem 30 is received within collar-locking cannula 300. The termination end of collar extension 308 in combination with guiding wall 312 form reception aperture 314. The retention process of tube bond stem 30/208 within collar-locking cannula 300 will now be described.
As mentioned above, collar-locking cannula 300 may be configured to quickly attach and detach from T-site connector 10 and/or T-site connector 200. While some descriptions herein may reference connection of collar-locking cannula 300 to T-site connector 10 or T-site connector 200 for clarity purposes, it is to be understood that collar-locking cannula 300 may be configured to attach to T-site connector 10 and T-site connector 200 in similar ways. When connecting collar-locking cannula 300 to T-site connector 10/200, tube bond stem 30/208 is received first within reception aperture 314 as collar-locking cannula 300 is translated towards proximal end 38/200a of T-site connector 10/200. Furthermore, as tube bond stem 30/208 is received within reception aperture 314, guiding wall 312 may guide tube bond stem 30/208 within reception aperture 314 and prevent rotation of collar-locking cannula 300 during initial translation of collar-locking cannula 300. During translation, externally threaded cap 36/230 is received within the hollowed-out middle of collar 304. In these embodiments, similar to the description above with relation to lever-locking cannula 16, external-threaded segment 94 of externally threaded cap 36 or one or more external threads 234 of externally threaded cap 230 are bypassed in this configuration. Said another way, in some embodiments in which collar-locking cannula 300 is used, externally threaded cap 36 and externally threaded cap 230 lack external-threaded segment 94 and one or more external threads 234, respectively.
Once tube bond stem 30/208 reaches the most proximal portion of reception aperture 314, tube bond stem 30/208 is then to be retained within retention aperture 310. To retain tube bond stem 30/208 within retention aperture 310, the user rotates collar-locking cannula 300 in a first direction with respect to T-site connector 10/200. For example, the user may grip proximal end 302 and rotate collar-locking cannula 300 in the first direction while holding T-site connector 10/200 stationary. Such rotation moves tube bond stem 30/208 from reception aperture 314 into retention aperture 310. Once tube bond stem 30/208 is rotated into retention aperture 310, collar-locking cannula 300 is prevented from moving distally, thereby maintaining insertion of cannula tip 298 within slit septum 34 or septum 260.
In some embodiments, collar extension 308 may include collar edge 308a, best illustrated in
As stated above with regards to lever-locking cannula 16, collar-locking cannula 300 may provide the advantage of rapid connection and disconnection of the proximal connection device from the T-site connector 10/200.
Various methods of using the above-described components will now be discussed. Some embodiments of the invention are directed to using at least one of the above-described components. Various methods may be utilized by medical professionals. Examples of medical professionals can include doctors, anesthesiologists, physician assistants, nurses, nurse practitioners, certified nursing assistants, medics, phlebotomists, emergency medical technicians, veterinarians, veterinary assistants, and others. Some embodiments of the methods may be performed by the patient, by a family member of the patient, by a friend of the patient, or other person.
Exemplary methods of some embodiments disclosed herein are shown in
Turning to
In a step 2200, the medical professional performs, on a forearm of a patient, an ultrasound vascular assessment. In an example of step 2200, the medical professional performs an ultrasound vascular assessment on a patient to locate a vein for insertion of catheter 12, or other VAD, into. The ultrasound vascular assessment identifies the size, location, and orientation of a target vein in the forearm of the patient. In prior art systems, vascular assessments have been used to identify and diagnose medical conditions, such as blood clots and other blockages, by evaluating the flow of blood through the veins and arteries. Because, as discussed above, T-site connector 10/200 uses a single injection access point for the duration of a patient stay at a medical establishment, the ultrasound vascular assessment may be used to ensure an accurate injection the first time. The ultrasound vascular assessment also allows the utilization of a vein in forearm (e.g., in the forearm below the elbow). While veins at the inner elbow are easier to access, they are more painful and prone to infection.
In a step 2202, the medical professional identifies, potentially based on the ultrasound vascular assessment performed at step 2200, a target vein in the forearm of the patient. In an example of step 2202, the medical profession identifies and labels a vein that may be capable of receiving and retaining catheter 12, or other VAD, for the duration of the stay of the patient, or an otherwise extended period of time (i.e., longer than a single injection period). As discussed above, the ultrasound vascular assessment may be used to determine which vein to utilize, ensure that it is accessible, and determine if the other forearm of the patient should be used instead. The identified vein may be marked or otherwise noted.
In a step 2204, the medical professional determines, potentially based on the ultrasound vascular assessment performed at step 2200, a size of catheter that is appropriate for the target vein. In an example of step 2204, the size of the catheter 12 may be determined based upon the approximate diameter of the vein, the orientation of the vein, the length of the vein that is proximate to the skin, and/or other considerations. Unlike prior art systems in which the size of catheter would be chosen based upon a standardization for a type of patient, embodiments disclosed herein allow for the size of catheter 12 to be chosen specifically for the patient.
In some embodiments, the size of the catheter 12 may be determined or suggested by a computer program that is associated with the ultrasound vascular assessment. For example, a computer program running or otherwise receiving data from the ultrasound may identify the vein and measure the width of the vein as detected by the ultrasound. The determined width of the vein (which corresponds to the diameter) may be used by the computer program to determine or calculate the correct size of catheter. It should be appreciated that the above-discussed computer program may be associated with a computerized method of performing the discussed steps or may be stored on a non-transitory computer readable storage medium such that execution of the computer program by a processor performs the discussed steps.
In a step 2206, the medical professional obtains the components needed. In an example of step 2206, the medical profession obtains a catheter 12 having the size determined in step 2204. The medical profession may also obtain any of T-site connector 10/200, lever-locking cannula 16, threaded-locking cannula 18, locking cannula 280, collar-locking cannula 300, and/or tube set 20. In some embodiments, the medical professional may also obtain the proximal medical device 128, such as a syringe 19, intravenous drip bags, blood draw vials, and the like. Other equipment for the injection may also be obtained, such as reconstitution solution (such as sterile water or specific diluent), alcohol swabs, cotton wool, the dressing to cover the injection site, and the like.
In a step 2208, the medical professional prepares an injection site on the forearm of the patient. In an example of step 2208, the medical profession prepares the injection site by applying a disinfectant to the site (such as an alcohol-based solution) and allowing the disinfectant to dry.
In a step 2210, the medical professional injects the catheter into the target vein of the forearm of the patient. In an example of step 2210, the medical professional injects catheter 12 into the forearm of the patient.
In a step 2212, the medical professional attaches a T-site connector to the catheter. In an example of step 2212, the medical professional attaches T-site connector 10/200 to catheter 12. Note that in some embodiments, T-site connector 10/200 may be attached to catheter 12 prior to the catheter 12 being injected into the target vein (i.e., step 2212 is performed prior to step 2210). The T-site connector 10/200 is then ready for usage as the single access point for the injection of medicaments to and withdrawal of blood from the patient's bloodstream. The medical professional may also place an antiseptic cap, such as port cover 156, over the externally threaded cap 36/230 to prevent infection.
Turning to
In a step 2300, the medical practitioner accesses the installed T-site connector (e.g., T-site connector 10/200). In an example of step 2300, the T-site connector 10/200 may have been installed, such as described above in regard to
First, connection of a lever-locking cannula will be discussed. In a step 2302, the medical practitioner acquires the lever-locking cannula (e.g., lever-locking cannula 16). In an example of step 2302, the lever-locking cannula may be (previously or subsequently) secured to a syringe (e.g., syringe 19), a vacutainer or other blood container, or other proximal medical device 128. In some embodiments, the lever-locking cannula 16 is used for single use, rapid injections. The lever-locking cannula 16 may be used to quickly attach and detach from the T-site connector 10/200 (or to and from other proximal connection devices). For example, a single application of a medicament may be performed by quickly attaching lever-locking cannula 16, injecting the medicament, and detaching lever-locking cannula 16.
In a step 2304, the medical practitioner compresses the pivot locks located on the lever-locking cannula. In an example of step 2304, the pivot locks (e.g., first pivot lock 114 and second pivot lock 116) on lever-locking cannula 16 are compressed, such as between a thumb and forefinger. The lever-locking cannula 16 is utilized by the medical professional applying slight inward pressure to each proximal lever 120. The inward pressure thus moves the distal clips 122 outward.
In a step 2306, the medical professional inserts the cannula of the lever-locking cannula into the septum of the T-site connector. In an example of step 2306, the distal clips 122 move outward, thereby allowing for the distal clips 122 to be installed around a flange (e.g., flange 56) located on the proximal end of the T-site connector, concurrently with the cannula piercing the septum (e.g., through slit 264 of septum 260).
In a step 2308, the medical professional releases the pivot locks. In an example of step 2308, the medical professional releases the inward pressure on the proximal lever 120 such that distal clips 122 are relaxed to a default, locked position.
Next, connection of a tube set 20 or threaded-locking cannula 18 will be discussed. In a step 2310, the medical professional acquires the tube set and/or threaded-locking cannula. In an example of step 2310, the medical profession acquires tube set 20 and/or threaded-locking cannula 18. The appropriate proximal connection devices may have one or more proximal medical devices 128 (such as a syringe 19, vacutainer, or the like) already attached thereto.
In a step 2312, the medical professional ensures that flow locks of the tube set are emplaced. In an example of step 2312, the medical professional emplaces flow locks 134 on tube set 20. In some embodiments, the tube set 20 includes a flow lock 134 on each line 132 (as discussed above). Such a configuration may prevent reflux out of the unused line 132 upon injection to or withdrawal from the other lines 132.
In a step 2314, the medical professional attaches the proximal connection devices to the proximal end of the T-site connector (e.g., to the externally threaded cap, to the antiseptic cap, or other component), or to the tube bond stem, depending on the application. In an example of step 2314, the medical professional may attach to the proximal end 200a of the T-site connector 200, a distal end of locking cannula 280. In another example of step 2314, the medical professional may attach to the proximal end 200a of T-site connector 200, a distal end of tube set 20 including the first access port 140, the second access port 146, and the third access port 152.
As described above, in embodiments in which threaded-locking cannula 18 or locking cannula 280 is attached to externally threaded cap 36/230, the degree of rotation necessary for fully securing threaded-locking cannula 18 or locking cannula 280 to externally threaded cap 36/230 may be decreased. For example, in some embodiments one or more external threads 104/234 may comprise an increased number of threads to decrease the degree of rotation required to secure threaded-locking cannula 18 or locking cannula 280 to externally threaded cap 36/230. For example, in some embodiments one or more external threads 104/234 may comprise three external threads and thereby require a rotation of between about 220 degrees to about 240 degrees of internally threaded collar 126/282 to fully secure threaded-locking cannula 18 or locking cannula 280 to externally threaded cap 104/234. Such a decrease in required rotation may make it easier for a user of T-site connector 10/200 to connect threaded-locking cannula 18 or locking cannula 280. For example, in practice a user may use two fingers to rotatably attach threaded-locking cannula 18 or locking cannula 280 to externally threaded cap 36/230. Accordingly, a rotation of 300 degrees or greater may make it difficult for the user to complete such a rotation without releasing and reengaging internally threaded collar 126/282. Further, increasing the number of external threads may increase the likelihood of engagement between internally threaded collar 126/282 and externally threaded cap 36/230. For example, less rotation may be required to cause insertion of the one or more external threads 104/234 into the internal threads disposed on internally threaded collar 126/282.
In some embodiments, the medical professional may connect the proximal connection device to the tube bond stem 30/208 via an intermediary tube segment 158, as illustrated in
The female luer lock 162 is configured to receive and connect to a male luer found on any needleless connector, syringe, or IV administration set. As mentioned above, by connecting female luer lock 162 to a syringe, for example, medicaments and/or liquids may be exchanged between the syringe and patient via secondary fluid passageway 48/210. The intermediary tube segment 158 may further comprise a flow lock 134, which may be similar or the same as flow locks 134 described in relation to
In a step 2316, a cannula is inserted into an access port. In an example of step 2316, cannula 24 is inserted into access port 22. In another example of step 2316, a proximal medical device 128, such as syringe 19, is connected to threaded-locking cannula 18 or locking cannula 280. The cannula, such as a blunt cannula, a needle, or other similarly shaped device, is used to access the interior of the proximal connection devices (which is in fluid communication with the primary fluid passageway 46/206 of the T-site body 26/202 and the patient blood stream). It should be noted that in some embodiments, this step is performed prior to the above-discussed steps, based upon the application.
In a step 2318, the medical professional prepares the access port. In an example of step 2318, the medical professional prepares the access port by removing port cover 156 if applicable and/or applying an antiseptic wipe.
In a step 2320, the medical professional injects a medicament into the T-site connector (and by extension, into the blood stream of the patient). In an example of step 2320, the medical professional injects a medicament from syringe 19, through T-site connector 10/200 and into the patient. This is best illustrated in
Steps 2322-26 illustrate three exemplary uses for tube set 20. It should be appreciated that the tube set 20 may have more or fewer access ports 22, and the access ports 22 may be used for additional or different functions. Similarly, as discussed above, the access ports 22 may have a distinctive color or marking designating the specific access port 22 for one or more specific purpose.
In a step 2322, the medical professional utilizes a first access port of the tube set. In an example of step 2322, the medical professional utilizes first access port 140 of tube set 20. In some embodiments, first access port 140 may be designated for the injection of medicaments. In this example of step 2322, the medical professional inserts in the first access port 140, a medicament cannula (e.g., cannula 24 associated with a medicament, such as syringe 19 or an intravenous drip bag). The medical professional removes a first flow lock 138 from the first line 136 associated with the first access port 140. This can be done by unclipping the first flow lock 138 so as to allow fluid to flow therethrough. The medical professional subsequently injects, into the patient, a medicament from the cannula 24 via the first access port 140.
In a step 2324, the medical professional utilizes the second access port of the tube set. In an example of step 2324, the medical professional utilizes the second access port 146 of tube set 20. In this example of step 2324, the medical professional inserts cannula 24 into the second access port 146. The medical professional removes the second flow lock 144 from the second line 142 associated with the second access port 146. This can be done by unclipping the second flow lock 144 so as to allow fluid to flow therethrough. The medical professional then flushes the T-site connector 10/200 by supplying a flushing liquid therein from the cannula 24 via the second access port 146. In some embodiments, second access port 146 may be designated for flushing the T-site body 26/202. Flushing may be performed to remove all residual medicament (such as an antibiotic) before a blood draw. Such flushing may be necessary, as having antibiotics in the blood draw may corrupt the sample. In another example, flushing may be performed periodically to reduce the risk of infection growing within the T-site body 26/202.
In a step 2326, the medical professional utilizes the third access port of the tube set. In an example of step 2326, the medical profession inserts, in the third access port 152 (or in the slit septum 34), a cannula 24 configured for drawing blood. The medical professional then removes the third flow lock 150 from the third line 148 associated with the third access port 152. As discussed above, this can be done by unclipping the third flow lock 150. The medical professional then draws blood from the patient into the cannula 24 via the third access port 152, and into an attached vacutainer or other proximal medical device 128.
In some embodiments, the third access port 152 may be designated for blood draw. In other embodiments, slit septum 34 or septum 260 is designated for blood draw. In prior art systems, each blood draw was performed by piercing an artery for each blood draw procedure. This method is painful to the patient, time consuming, and prone to infection, as discussed above. Further, it is typical in prior art systems for the medical professional to draw far more blood than is needed for a given medical test. For example, it is standard to fill an entire 10 mL vacutainer, even when only 2 mL is needed for a test. The remainder is wasted. This can be problematic, for example, because a draw of 50 mL can drop hemoglobin by 18%. Because the blood draw procedure is performed independently, it has been standard to fill an entire vacutainer regardless of need. One goal of the current invention, therefore, may be to reduce the amount of blood drawn to more specifically match the test to be performed. Because the procedure is simplified from prior art systems, the medical professional may draw only as much blood as is needed.
In some embodiments, following the blood draw, the blood within one or more lines 132 may be returned to the patient by flushing. This can include applying a flushing cannula (e.g., cannula 24) to the first access port 140 and/or the third access port 152. Returning the blood to the patient can be important for some patients, especially those with low hemoglobin levels and other medical issues. Returning the blood to the patient allows for minimal wastage of blood. Returning the blood to the patient also reduces the risk of blood stream infection because the blood is not allowed to remain within the T-site connector 10/200 for an extended period of time, where an infection may develop.
It should also be appreciated that the discussed steps may be performed independently of the other discussed steps. For example, the flushing discussed in step 2324 may be performed before the blood draw discussed in step 2326, and the injection of the medicament described in step 2322 may be performed independently.
In a step 2328, the medical professional emplaces the flow lock that was removed to allow for access to the access port. In an example of step 2328, the medical professional emplaces the flow lock 134 that was removed to allow for access to the access port 22. In this example of step 2328, the flow lock 134 is emplaced by clipping the respective flow lock 134 so as to prevent fluid to flow therethrough. This prevents reflux of blood and/or the medicament from escaping when the cannula 24 is withdrawn, because the back pressure (e.g., from the blood stream of the patient) is cut off by the flow lock 134.
In a step 2330, a common step to any proximal connection device, the medical professional removes the cannula from the T-site connector. In an example of step 2330, the medical professional removes cannula 24 from T-site connector 10/200. The cannula 24 is then typically discarded, such as in a sharp disposal box. The medical professional may then apply an antiseptic cap to the access port 22, wipe the access port 22 with an antiseptic, and/or perform other sanitary functions so as to prevent or reduce the chance of infection.
Features described above as well as those claimed below may be combined in various ways without departing from the scope hereof. The following examples illustrate some possible, non-limiting combinations:
Although the invention has been described with reference to the embodiments illustrated in the attached drawing figures, it is noted that equivalents may be employed and substitutions made herein without departing from the scope of the invention as recited in the claims.
Having thus described various embodiments of the invention, what is claimed as new and desired to be protected by Letters Patent includes the following: